Clinical evaluation of the branched DNA assay for hepatitis B virus DNA detection in patients with chronic hepatitis B lacking hepatitis B e antigen and treated with interferon-α

Journal of Viral Hepatitis

Volumn 5, Issue 6, 1998, Pages 407-414

  Habersetzer, F ^a,b,f   Zoulim, F ^a,b   Jusot, J F ^a,c   Zhang, X ^a   Trabaud, M A ^b,c   Chevallier, P ^c   Chevallier, M ^d   Ahmed, S N S ^a   Sepetjan, M ^c   Comanor, L ^e   Minor, J ^e   Trepo C ^a,b  

^a HÔTEL DIEU   (France)

^b INSERM   (France)

^c Lab d'Explorations Fonctionnelles   (France)

^d CNRS   (France)

^e NOVARTIS PHARMA AG   (Switzerland)

^f HÔPITAL CIVIL   (France)

Author keywords

Branched DNA (bDNA) signal amplification; HBeAg negative chronic hepatitis; Hepatitis B virus (HBV) DNA

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; DNA; HEPATITIS B(E) ANTIGEN; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA;

ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; HEPATITIS B; HUMAN; HYBRIDIZATION; LIVER BIOPSY; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANTIVIRAL AGENTS; DNA, VIRAL; EVALUATION STUDIES; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON ALFA-2B; MUTATION; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VIRAL CORE PROTEINS;

EID: 0031739868     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1998.00128.x     Document Type: Article

References (41)

1. Perrillo RP. Interferon in the management of chronic hepatitis B. Dig Dis Sci 1993; 38: 577-593.
2. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336: 347-356.
3. Carman WF, Jacyna MR, Hadziyannis S et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; 2: 588-591.
4. Brown JL, Carman WF, Thomas HC. The clinical significance of molecular variation within the hepatitis B genome. Hepatology 1992; 15: 144-148.
5. Okamoto H, Yotsumoto S, Akahane Y et al. Hepatitis B viruses with precore defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990; 64: 1298-1303.
6. Quint WGV, Heijtink RA, Schirm J, Gerlich WH, Niesters HGM. Reliability of methods for hepatitis B virus DNA detection. J Clin Microbiol 1995; 33: 225-228.
7. Zoulim F, Mimms L, Floreani M et al. New assays for quantitative determination of viral markers in management of chronic hepatitis B virus infection. J Clin Microbiol 1992; 30: 1111-1119.
8. Hendricks DA, Stowe BJ, Hoo BS et al. Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol 1995; 104: 537-546.
9. Urdea MS, Running JA, Horn T, Clyne J, Ku L, Warner BD. A novel method for the rapid detection of specific nucleotide sequences in crude biological samples without blotting or radioactivity; application to the analysis of hepatitis B virus in human serum. Gene 1987; 61: 253-264.
10. Zaaijer HL, ter Borg F, Cuypers HT, Hermus MC, Lelie PN. Comparison of methods for detection of hepatitis B virus DNA. J Clin Microbiol 1994; 32: 2088-2091.
11. Chen C-H, Wang J-T, Lee C-Z, Sheu J-C, Wang T-H, Chen D-S. Quantitative detection of hepatitis B virus DNA in human sera by branched-DNA signal amplification. J Virol Methods 1995; 53: 131-137.
12. Butterworth LA, Prior SL, Buda PJ, Faoagali JL, Cooksley WG. Comparison of four methods for quantitative measurement of hepatitis B viral DNA. J Hepatol 1996; 24: 686-691.
13. Hwang SJ, Lee SD, Lu RH et al. Comparison of three different hybridization assays in the quantitative measurement of serum hepatitis B virus DNA. J Virol Methods 1996; 62: 123-129.
14. Khakoo SI, Soni PN, Brown D, Dusheiko GM. A clinical evaluation of a new method for HBV DNA quantitation in patients with chronic hepatitis B. J Med Virol 1996; 50: 112-116.
15. Kapke GF, Watson G, Sheffler S, Hunt D, Frederick C. Comparison of the Chiron Quantiplex branched DNA (bDNA) assay and the Abbott Genostics solution hybridization assay for quantification of hepatitis B viral DNA. J Viral Hep 1997; 4: 67-75.
16. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
17. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
18. Hoofnagle JH, Peters M, Mullen KD et al. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology 1988; 95: 1318-1325.
19. Brook MG, McDonald JA, Karayiannis P et al. Randomized controlled trial of interferon alpha 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response. Gut 1989; 30: 1116-1122.
20. Perrillo RP, Schiff ER, Davis GL et al. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med 1990; 323: 295-301.
21. Lok ASF, Wu P-C, Lai C-L et al. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology 1992; 102: 2091-2097.
22. Di Bisceglie AM, Fong TL, Fried MW et al. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B. Am J Gastroenterol 1993; 88: 1887-1892.
23. Kuhns MC, McNamara AL, Perrillo RP, Cabal CM, Campbell CR. Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy. J Med Virol 1989; 27: 274-281.
24. Cova L, Lambert V, Chevallier A et al. Evidence for the presence of duck hepatitis B viruses in wild migrating ducks. J Gen Virol 1986; 67: 537-547.
25. Chemin I, Baginski I, Petit MA et al. Correlation between HBV DNA detection by polymerase chain reaction and Pre-S1 antigenemia in symptomatic and asymptomatic hepatitis B virus infections. J Med Virol 1991; 33: 51-57.
26. Li J, Tong S, Vitvitski L, Zoulim F, Trépo C. Rapid detection and further characterization of infection with hepatitis B virus variants containing a stop codon in the distal pre-C region. J Gen Virol 1990; 71: 1993-1998.
27. Zhang X, Zoulim F, Habersetzer F, Xiong S, Trépo C. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B. J Med Virol 1996; 48: 8-16.
28. Kshirsager AM. In: Owen DB, ed. Multivariate Analysis, Vol. 2. New York: Marcel Dekker, 1972: 206-214.
29. Lau DT-Y, Comanor L, Minor JM, Everhart JE, Wuestehube LJ, Hoofnagle JH. Statistical models for predicting a beneficial response to intereferon-α in patients with chronic hepatitis B. J Viral Hep 1998; 5: 105-114.
30. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333: 1657-1661.
31. Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA 1996; 93: 4398-4402.
32. Mangia A, Chung YH, Hoofnagle JH, Birkenmeyer L, Mushahwar I, Di Bisceglie AM. Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg. Dig Dis Sci 1996; 41: 2447-2452.
33. Fattovich G, Brollo L, Alberti A, Pontisso P, Giustina G, Realdi G. Long-term follow-up of anti-HBe-positive chronic active hepatitis B. Hepatology 1988; 8: 1651-1654.
34. Bonino F, Rosina F, Rizzetto M et al. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 1986; 90: 1268-1273.
35. Fujiwara K, Yokosuka O, Ehata T et al. The two different states of hepatitis B virus DNA in asymptomatic carriers: HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers. Dig Dis Sci 1998; 43: 368-376.
36. Jardi R, Buti M, Rodriguez-Frias F et al. The value of quantitative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection. J Hepatol 1996; 24: 680-685.
37. Dybowski R, Weller P, Chang R, Gant V. Prediction of outcome in critically ill patients using artificial neural network synthesized by genetic algorithm. Lancet 1996; 347: 1146-1502.
38. Minor JM, Namini H. Analysis of clinical data using neural nets. J Biopharm Statist 1996; 6: 83-104.
39. Fattovich G, Farci P, Rugge M et al. A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg. Hepatology 1992; 15: 584-589.
40. Brunetto MR, Giarin M, Saracco G et al. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B. Gastroenterology 1993; 105: 845-850.
41. Lampertico P, Del Ninno E, Manzin A et al. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum. Hepatology 1997; 26: 1621-1625.